CUMYL-CBMINACA (SGT-277) is an
indazole
Indazole, also called isoindazole, is a heterocyclic aromatic organic compound. This bicyclic compound consists of the fusion of benzene and pyrazole.
Indazole is an amphoteric molecule which can be protonated to an indazolium cation or deprotona ...
-3-carboxamide based
synthetic cannabinoid
Synthetic cannabinoids, or neocannabinoids, are a class of designer drug molecules that Binding affinity, bind to the same receptors to which cannabinoids (Tetrahydrocannabinol, THC, Cannabidiol, CBD and many others) in cannabis plants attach. Th ...
receptor agonist that has been sold as a
designer drug
A designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug, while avoiding classification as illegal and/or detection in standard drug tests. ...
,
first being identified in Germany in February 2020. It is illegal in Finland.
See also
*
CUMYL-3TMS-PRINACA
CUMYL-3TMS-PRINACA is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first identified in Sweden in May 2023. Along with the related compound ADMB-3TMS-PRINACA that was reported sever ...
*
CUMYL-CBMICA
*
CUMYL-CH-MEGACLONE
*
CUMYL-CHMICA
*
CUMYL-THPINACA
References
Cannabinoids
Designer drugs
Cyclobutyl compounds
Indazoles
{{cannabinoid-stub